Chemours (CC)
Chemours Statistics
Share Statistics
Chemours has 149.44M shares outstanding. The number of shares has increased by 0.41% in one year.
Shares Outstanding | 149.44M |
Shares Change (YoY) | 0.41% |
Shares Change (QoQ) | 0.09% |
Owned by Institutions (%) | 84.17% |
Shares Floating | 148.42M |
Failed to Deliver (FTD) Shares | 56 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.31M, so 4.89% of the outstanding shares have been sold short.
Short Interest | 7.31M |
Short % of Shares Out | 4.89% |
Short % of Float | 4.92% |
Short Ratio (days to cover) | 4.37 |
Valuation Ratios
The PE ratio is 29.38 and the forward PE ratio is 8.74. Chemours's PEG ratio is -0.22.
PE Ratio | 29.38 |
Forward PE | 8.74 |
PS Ratio | 0.44 |
Forward PS | 0.3 |
PB Ratio | 4.18 |
P/FCF Ratio | -2.54 |
PEG Ratio | -0.22 |
Enterprise Valuation
Chemours has an Enterprise Value (EV) of 7.19B.
EV / Earnings | 83.59 |
EV / Sales | 1.24 |
EV / EBITDA | 10.39 |
EV / EBIT | 15.73 |
EV / FCF | -7.24 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 7.21.
Current Ratio | 1.68 |
Quick Ratio | 0.86 |
Debt / Equity | 7.21 |
Total Debt / Capitalization | 87.82 |
Cash Flow / Debt | -0.15 |
Interest Coverage | 1.73 |
Financial Efficiency
Return on equity (ROE) is 0.14% and return on capital (ROIC) is 6.24%.
Return on Equity (ROE) | 0.14% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | 6.24% |
Revenue Per Employee | $963,666.67 |
Profits Per Employee | $14,333.33 |
Employee Count | 6,000 |
Asset Turnover | 0.77 |
Inventory Turnover | 3.15 |
Taxes
Income Tax | 41M |
Effective Tax Rate | 0.32 |
Stock Price Statistics
The stock price has increased by -45.54% in the last 52 weeks. The beta is 1.98, so Chemours's price volatility has been higher than the market average.
Beta | 1.98 |
52-Week Price Change | -45.54% |
50-Day Moving Average | 16.55 |
200-Day Moving Average | 19.27 |
Relative Strength Index (RSI) | 43.14 |
Average Volume (20 Days) | 2.58M |
Income Statement
In the last 12 months, Chemours had revenue of 5.78B and earned 86M in profits. Earnings per share was 0.58.
Revenue | 5.78B |
Gross Profit | 1.15B |
Operating Income | 457M |
Net Income | 86M |
EBITDA | 692M |
EBIT | 457M |
Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 713M in cash and 4.36B in debt, giving a net cash position of -3.64B.
Cash & Cash Equivalents | 713M |
Total Debt | 4.36B |
Net Cash | -3.64B |
Retained Earnings | 1.72B |
Total Assets | 7.51B |
Working Capital | 1.22B |
Cash Flow
In the last 12 months, operating cash flow was -633M and capital expenditures -360M, giving a free cash flow of -993M.
Operating Cash Flow | -633M |
Capital Expenditures | -360M |
Free Cash Flow | -993M |
FCF Per Share | -6.64 |
Margins
Gross margin is 19.91%, with operating and profit margins of 7.9% and 1.49%.
Gross Margin | 19.91% |
Operating Margin | 7.9% |
Pretax Margin | 2.2% |
Profit Margin | 1.49% |
EBITDA Margin | 11.97% |
EBIT Margin | 7.9% |
FCF Margin | -17.17% |
Dividends & Yields
CC pays an annual dividend of $1, which amounts to a dividend yield of 6.69%.
Dividend Per Share | $1.00 |
Dividend Yield | 6.69% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 175.44% |
Earnings Yield | 4.06% |
FCF Yield | -46.47% |
Analyst Forecast
The average price target for CC is $22, which is 53.8% higher than the current price. The consensus rating is "Buy".
Price Target | $22 |
Price Target Difference | 53.8% |
Analyst Consensus | Buy |
Analyst Count | 9 |
Scores
Altman Z-Score | 1.64 |
Piotroski F-Score | 5 |